Cloxacilin
FPS-COL-2013-06
Phase 3 small_molecule terminated
Quick answer
Cloxacilin for Staphylococcus is a Phase 3 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Staphylococcus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated